Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Escribano

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Allergy and Clinical Immunology|February 14, 2013
Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosisCristina Teodosio, Andrés C García-Montero, María Jara-Acevedo, et al.
Histopathology|October 12, 2013
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosisJosé M Morgado, Omar Perbellini, Ryan C Johnson, et al.
International Archives of Allergy and Immunology|November 2, 2011
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalPeter Valent, Cem Akin, Michel Arock, et al.
Blood|January 18, 2013
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosisJason Gotlib, Animesh Pardanani, Cem Akin, et al.
Blood|August 14, 2025
Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detectionPaula Navarro-Navarro, María González-Tablas, Alba Pérez-Pons, et al.
The Journal of Allergy and Clinical Immunology|January 8, 2008
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxisDavid González de Olano, Iván Alvarez-Twose, María I Esteban-López, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2013
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SMIván Alvarez-Twose, Roberta Zanotti, David González-de-Olano, et al.
Blood Advances|October 31, 2018
Impact of somatic and germline mutations on the outcome of systemic mastocytosisJavier I Muñoz-González, María Jara-Acevedo, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2010
Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptomsIván Alvarez-Twose, David González de Olano, Laura Sánchez-Muñoz, et al.
Wiener Klinische Wochenschrift|June 9, 2005
The European Competence Network on Mastocytosis (ECNM)Peter Valent, Michel Arock, Stephan C Bischoff, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Allergy and Clinical Immunology|February 14, 2013
Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosisCristina Teodosio, Andrés C García-Montero, María Jara-Acevedo, et al.
Histopathology|October 12, 2013
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosisJosé M Morgado, Omar Perbellini, Ryan C Johnson, et al.
International Archives of Allergy and Immunology|November 2, 2011
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalPeter Valent, Cem Akin, Michel Arock, et al.
Blood|January 18, 2013
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosisJason Gotlib, Animesh Pardanani, Cem Akin, et al.
Blood|August 14, 2025
Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detectionPaula Navarro-Navarro, María González-Tablas, Alba Pérez-Pons, et al.
The Journal of Allergy and Clinical Immunology|January 8, 2008
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxisDavid González de Olano, Iván Alvarez-Twose, María I Esteban-López, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2013
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SMIván Alvarez-Twose, Roberta Zanotti, David González-de-Olano, et al.
Blood Advances|October 31, 2018
Impact of somatic and germline mutations on the outcome of systemic mastocytosisJavier I Muñoz-González, María Jara-Acevedo, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2010
Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptomsIván Alvarez-Twose, David González de Olano, Laura Sánchez-Muñoz, et al.
Wiener Klinische Wochenschrift|June 9, 2005
The European Competence Network on Mastocytosis (ECNM)Peter Valent, Michel Arock, Stephan C Bischoff, et al.
Pageof 7